Transaction · 0000914190-26-000120

Geist William

Geist William, PRES, PS, reported a transaction classified as exercise at BIO-TECHNE Corp involving 6416.000000 shares for an estimated $0.00. Reported holdings after the transaction were 26919.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MPRES, PS
TECHBIO-TECHNE Corp
Trade date
Aug 15, 2026
Filing date
Aug 18, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded6.41k$0.00 per share
Holdings after26.9kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TECH price since this filing

Daily closing prices, with the filing date and available return windows
TECH · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -0.6%1w ago +0.1%1d ago +0.2%
Returns since7d +0.2%30d +0.3%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0000914190-26-000120
Common Stock
Transaction date
Aug 15, 2026
Filed Aug 18, 2026, 09:13 PM · 3d delay
Shares
6,416 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
26,919 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
Filing-only score

+6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

PRESIDENT, PROTEIN SCIENCES

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

  2. F2

    100% vested.

  3. F3

    On 8/15/2026, the Board of Directors authorized discretionary vesting for 567 performance RSUs. The remainder of the performance RSUs were forfeited.

  4. F4

    Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026.

  5. F5

    On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,526 performance options. The remainder of the performance options were forfeited.

  6. F6

    Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

  7. F7

    2,623 restricted stock units vest on each of 8/15/2026 and 8/15/2027.

  8. F8

    Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.

  9. F9

    Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

  10. F10

    3,226 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028.

  11. F11

    Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028.

Original filing · 0000914190-26-000120
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TECH